L, B., ME, T., PH, O., V, K., K, B., & SE, E. (2026). Next-generation heparin antidotes: "Exosomes as a biocompatible alternative to protamine sulfate". Molecular biology reports, 53(1), . https://doi.org/10.1007/s11033-026-12145-7
Chicago Style (17th ed.) CitationL, Bahar, Tüysüz ME, Omay PH, Kınay V, Büyükafşar K, and Ertürk SE. "Next-generation Heparin Antidotes: "Exosomes as a Biocompatible Alternative to Protamine Sulfate"." Molecular Biology Reports 53, no. 1 (2026). https://doi.org/10.1007/s11033-026-12145-7.
MLA (9th ed.) CitationL, Bahar, et al. "Next-generation Heparin Antidotes: "Exosomes as a Biocompatible Alternative to Protamine Sulfate"." Molecular Biology Reports, vol. 53, no. 1, 2026, https://doi.org/10.1007/s11033-026-12145-7.